Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ensign GroupENSG -1.27%91 Debt-to-EBITDA is 3.37 as of Jun. 2026, which is 15% below its 10-year median of 3.95. GuruFocus rates ENSG with a GF Score™ of 91/100 and a GF Value™ of $183.09 (Fairly Valued). The stock has 3 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Ensign Group ranks worse than 66.95% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Ensign Group's Debt-to-EBITDA or its related term are showing as below:
ENSG'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.85 Med: 3.95 Max: 7.37
Current: 3.62
During the past 13 years, the highest Debt-to-EBITDA Ratio of Ensign Group was 7.37. The lowest was 1.85. And the median was 3.95.
ENSG's Debt-to-EBITDA is ranked worse than 66.95% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs ENSG: 3.62
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Ensign Group Debt-to-EBITDA Related Terms
Ensign Group Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Ensign Group's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ensign Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ensign Group Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ensign Group's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Ensign Group (ENSG) has a Debt-to-EBITDA of 3.37 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ensign Group. This is 15% below median its historical median of 3.95. Over the past decade, Ensign Group's Debt-to-EBITDA has ranged from 1.85 to 7.37. According to the industry distribution chart, Ensign Group ranks #320 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 66.9%.
Is Ensign Group's Debt-to-EBITDA too high?
Ensign Group's current Debt-to-EBITDA of 3.37 is 15% below median its 10-year median of 3.95. Over the past 10 years, this metric has ranged from a low of 1.85 to a high of 7.37. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Ensign Group's value of 3.37 is 53.5% above this industry median. Based on the distribution chart, Ensign Group ranks #320 out of 478 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ensign Group has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ensign Group's Debt-to-EBITDA compare to UHS and EHC?
According to the Healthcare Providers & Services industry distribution chart, Ensign Group ranks #320 out of 478 companies for Debt-to-EBITDA. This places Ensign Group in the lower half of its industry. The industry median Debt-to-EBITDA is 2.20. Ensign Group's value of 3.37 is 53.5% above this benchmark. Historically, Ensign Group's own Debt-to-EBITDA has ranged from 1.85 to 7.37 over the past decade. While the company's 10-year median is 3.95 vs. the industry median of 2.20, Ensign Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ensign Group's current Debt-to-EBITDA of 3.37 is 53.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Ensign Group. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ensign Group's current Debt-to-EBITDA is 3.37, which is 15% below median its own 10-year median of 3.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ensign Group stock overvalued right now?
Based on GuruFocus' analysis, Ensign Group (ENSG) is currently considered Fairly Valued. The stock's GF Value™ is $183.09, compared to a current price of $180.21 — trading 1.6% below its estimated fair value. The current Debt-to-EBITDA is 3.37, which is 15% below median its 10-year median of 3.95 and 53.5% above the Healthcare Providers & Services industry median of 2.20. Ensign Group's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Ensign Group (ENSG), the current Debt-to-EBITDA is 3.37 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ensign Group (ENSG) Overvalued in 2026?
Based on GuruFocus' analysis, Ensign Group stock appears to be undervalued.
The current stock price of $180.21 is trading 1.6% below its estimated GF Value™ of $183.09.
GuruFocus considers Ensign Group to be Fairly Valued.
Key valuation signals for ENSG:
Debt-to-EBITDA: 3.37 (15% below median its 10-year median of 3.95)
GF Value™: $183.09 vs. price of $180.21 (1.6% below fair value)
Industry Position: 53.5% above the Healthcare Providers & Services median (#320 of 478)
No single metric tells the full story. See the ENSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
91GF Score
Get the complete analysis for ENSG
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENSG has been successfully added to your 
